President-elect Donald J. Trump has named Jay Bhattacharya as the new director of the National Institutes of Health (NIH) for his upcoming term. Bhattacharya, a professor at Stanford University known for his criticism of pandemic lockdowns, will lead federal medical research initiatives. He is set to collaborate with Trump’s nominee for Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr.
Bhattacharya is a co-author of the Great Barrington Declaration, which encouraged re-evaluating stringent COVID-19 measures. This stance led to him being placed on a “Trends Blacklist” by Twitter, as revealed in the 2022 “Twitter Files.”
The President-elect expressed confidence in the new appointments, stating an aim of elevating the NIH‘s medical research standards. Subsequently, Bhattacharya—who obtained his medical degree and economics doctorate from Stanford—expressed gratitude for the nomination. Additionally, he promised reforms to restore public trust in American scientific bodies, saying he hopes to leverage scientific advancements for national health improvements.
Bhattacharya’s appointment requires Senate confirmation. Consequently, this will be taken up by a Republican majority in the chamber in January after President-elect Trump takes the Oath of Office. The NIH, consisting of 27 institutes and centers, employs around 20,000 staff and handles tasks like overseeing the National Institute of Allergy and Infectious Diseases and the National Cancer Institute. These centers focus on specific diseases and research areas.
The NIH is responsible for distributing nearly $31 billion annually in research grants for conditions affecting public health. The organization has faced scrutiny from several Republican lawmakers over funding to the Wuhan Institute of Virology, linked to gain-of-function research prior to the COVID-19 outbreak. Former NIH leaders, including Dr. Anthony Fauci and Dr. Francis Collins, have denied knowledge of any U.S.-funded modifications on viruses at that facility despite evidence to the contrary.